“The bitterness of poor quality remains after the sweetness of a low price is forgotten.” (Benjamin Franklin)
ITS products and solutions may be considered as (relatively) expensive. Don’t always expect the lowest bid/price from us. We know and understand what it takes to consistently deliver high quality and innovative drug testing point of care solutions, products and services. We listen and understand what is of use to our customers and what gives them high value for money. We are ready to walk away if somebody expects us to discount the price down to the point when we compromise the quality, or the future of our business. Why – because, at the end of the day, low price can be very costly for both the customer and the supplier. ITS believe that you just can’t consider price in isolation from quality. Quality of products. Quality of service.
“Price has no meaning without a measure of the quality being purchased.” (W. Edwards Deming)
Our business is built upon 3 pillars as shown in our logo – Quality. Innovation. Trust. These are values that we respect on a day to day basis throughout our business.
Police Scotland say 185 drivers failed roadside drug tests during their festive campaign. For the 1st time officers were able to test for drugs at the roadside. Drug tests for cannabis & cocaine resulted in 185 positive results from 480 drivers stopped. Almost 600 motorists breathalysed between 1 Dec-2 Jan were under the influence of drink/drugs. A total of 8687 drivers were stopped over the period, with 580 of those detected for drink/drug offences. 29 drivers were caught the morning after they had been drinking.
Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?
Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018. The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.